Tvardi Therapeutics, Inc. (TVRD)
$1.78-4.30%Close
SELLCRISIS · day 29
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $17M
- Avg volume
- 2.2M
- Beta
- 0.39
- P/E (TTM)
- -0.64
- Short % float
- 4.32%
- Days to cover
- 1.0
- SI change
- -51.7%
- 1W
- -4.30%
- 1M
- -29.08%
- 3M
- -50.14%
- YTD
- -56.37%
- vs SPY 1W
- -3.11%
- vs SPY 1M
- -32.40%
- vs SPY 3M
- -52.53%
- vs SPY YTD
- -68.13%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- NEUPBUYNeuphoria Therapeutics Inc.RECOVERYQ -13$3.95+1.02%
- SUPNBUYSupernus Pharmaceuticals, Inc.RECOVERYQ 27$45.11-1.61%
- ZJYLBUYJin Medical International Ltd.CRISISQ 4$3.04+0.00%
- NRCBUYNational Research CorporationRECOVERYQ 3$21.92-1.22%
- JSPRBUYJasper Therapeutics, Inc.CRISISQ -12$0.72+0.00%
- TFXBUYTeleflex IncorporatedBULLQ 10$138.31-0.37%
- APVOBUYAptevo Therapeutics Inc.CRISISQ -28$2.41-10.07%
- GANXBUYGain Therapeutics, Inc.RECOVERYQ -12$2.00-0.50%
- ZNTLSELLZentalis Pharmaceuticals, Inc.CRISISQ -5$3.76-1.83%
- COGTSELLCogent Biosciences, Inc.BEARQ 14$36.23-1.36%
- DRTSBUYAlpha Tau Medical Ltd.BULLQ 16$14.70-1.47%
- NXTCBUYNextCure, Inc.CRISISQ -7$5.89-6.36%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 17
- VALUE
- 17
- GROWTH
- 45
- GARP
- 5
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-87.2%
REV YoY-
ROE-145.4%
EPS YoY-
ROA-148.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.64
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.99
P/FCF-
EV/EBITDA-0.04
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E1.73
ALTMAN Z-
CURR RATIO1.87
ND/EBITDA-
BETA0.39
